Migraine Trial, Recruiting (NCT06203873)

Migraine Trial, Recruiting NCT06203873 Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital Condition: Migraine

Printed from Voxsanity (voxsanity.com.au) — NCT06203873 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Migraine

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 65 years old
You have been diagnosed with migraine according to standard medical guidelines (called ICHD-3)
You have had migraines for more than 1 year, and they seriously affect your everyday life
You have been diagnosed with a small hole in the heart called a "patent foramen ovale" (PFO) that allows blood to flow in the wrong direction, confirmed by a heart scan (confirm with trial site)
You are willing to take part and attend follow-up appointments
You have already tried at least three different types of migraine prevention medications, and none of them reduced your migraines by 50% or more

Who may not be able to join:

Your migraines are caused by another underlying condition rather than being a primary migraine disorder
You have a history of a mini-stroke (TIA) or stroke
You have a reason why you cannot take blood-thinning or anti-clotting medications, or you are allergic to them
You have a medical reason why the procedure to close the hole in your heart (PFO closure) would not be safe for you (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8688396666

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06203873

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Migraine

Trial contact: 8688396666

More information: https://clinicaltrials.gov/study/NCT06203873

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 65 years old
You have been diagnosed with migraine according to standard medical guidelines (called ICHD-3)
You have had migraines for more than 1 year, and they seriously affect your everyday life
You have been diagnosed with a small hole in the heart called a "patent foramen ovale" (PFO) that allows blood to flow in the wrong direction, confirmed by a heart scan (confirm with trial site)
You are willing to take part and attend follow-up appointments
You have already tried at least three different types of migraine prevention medications, and none of them reduced your migraines by 50% or more

Who may not be able to join:

Your migraines are caused by another underlying condition rather than being a primary migraine disorder
You have a history of a mini-stroke (TIA) or stroke
You have a reason why you cannot take blood-thinning or anti-clotting medications, or you are allergic to them
You have a medical reason why the procedure to close the hole in your heart (PFO closure) would not be safe for you (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Chinese Academy of Medical Sciences, Fuwai Hospital

Registry

ClinicalTrials.gov

Start date

1 March 2024

Est. completion

1 March 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Reduced days per month at 12 month's follow-up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov